For the Inventor, By the Inventor

Enter assignee name

St. Louis, MO, United States of America

Medibeacon Inc.

USPTO Granted Patents = 59

CIPO Patents = 1

EPO Patents = 13

Trademarks = 7

Forward Citations = 181

Loading Chart...

Loading Chart...

49 inventors (with patents filed for the assignee):

Richard Bradley Dorshow (34 out of 95 patents)

Raghavan Rajagopalan (25 out of 118 patents)

William L Neumann (21 out of 57 patents)

4. Thomas Edward Rogers (10 out of 55 patents)

5. Dennis A Moore (9 out of 29 patents)

6. Kate LeeAnn Bechtel (7 out of 95 patents)

7. Jennifer Keating (6 out of 6 patents)

8. Edward Gerald Solomon (6 out of 47 patents)

9. Kimberly Merritt Shultz (6 out of 15 patents)

10. Scott T Depierro (5 out of 6 patents)

11. Steven J Hanley (5 out of 5 patents)

12. Johannes Pill (5 out of 20 patents)

13. Daniel Schock-Kusch (5 out of 7 patents)

14. Phillip I Tarr (4 out of 4 patents)

15. Bob O Basore (4 out of 4 patents)

Core Competencies:

Fluorescent Tracers

Transcutaneous Measurement

Vascular Closure Devices

Optical Agents

Renal Monitoring

Gut Function Assessment

Diaminopyrazine

Sensor Technologies

Photoactive Agents

Tissue Sealants

Non-Invasive Monitoring

59 patents: Sort by Forward Citations

1. 12692240 - Method for preparing 3,6-diaminopyrazine-2,5-dicarboxylic acid and synthetic intermediate thereof (2026-07-28),

2. 12428382 - Purification of substituted diaminopyrazine dicarboxylic acids (2025-09-30),

3. 12319660 - Preparation of substituted diaminopyrazine dicarboxylic acids (2025-06-03),

4. 12303570 - Compositions and methods for assessing eye vasculature (2025-05-20),

5. 12257048 - Method for non-invasive monitoring of fluorescent tracer agent with diffuse reflecting medium with time-varying optical properties (2025-03-25),

6. 12257027 - Transcutaneous organ function measurement (2025-03-25),

7. D1052412 - Sensor (2024-11-26),

8. D1051738 - Sensor ring (2024-11-19),

9. 12102432 - Uses of transdermal glomerular filtration rate measurement in continuous renal replacement therapy (2024-10-01),

10. 12048751 - Compositions and methods for assessing gut function (2024-07-30),

11. 12036022 - Transcutaneous organ function measurement (2024-07-16),

12. 11969268 - Systems and methods for home transdermal assessment of gastrointestinal function (2024-04-30),

13. 11950907 - Method for non-invasive monitoring of fluorescent tracer agent with diffuse reflecting medium with time-varying optical properties (2024-04-09),

14. 11708336 - Anodic oxidation of 5-aminouracil (2023-07-25),

15. 11674965 - Method for preparing and analyzing fluorescent compounds in plasma (2023-06-13),

Medibeacon Inc., based in St. Louis, MO, specializes in advanced fluorescent compounds and sensor technologies aimed at enhancing medical diagnostics and monitoring. The company focuses on developing innovative solutions such as fluorescent tracers and optical agents for transcutaneous measurement, particularly in renal monitoring and gut function assessment. Their expertise extends to vascular closure devices, leveraging cutting-edge technology to improve patient outcomes and streamline medical procedures.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Medibeacon Inc.

59 Patents

#43 in St. Louis, MO

#74 in Missouri

#6,069 in US

#12,226 in the World

St. Louis, MO, United States of America

Medibeacon Inc.

Forward Citations = 181

49 inventors:

Richard Bradley Dorshow (34 out of 95 patents)

Raghavan Rajagopalan (25 out of 118 patents)

William L Neumann (21 out of 57 patents)

4. Thomas Edward Rogers (10 out of 55 patents)

5. Dennis A Moore (9 out of 29 patents)

Please report any incorrect information to [email protected]

Loading…